| For: | Samanta A, Sen Sarma M. Metabolic dysfunction-associated steatotic liver disease: A silent pandemic. World J Hepatol 2024; 16(4): 511-516 [PMID: 38689742 DOI: 10.4254/wjh.v16.i4.511] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i4/511.htm |
| Number | Citing Articles |
| 1 |
М. В. Турчин, І. М. Кліщ. ВПЛИВ ЛІПІДНОГО ТА ВУГЛЕВОДНОГО ОБМІНУ НА СТРУКТУРНІ ЗМІНИ ОКА У ПАЦІЄНТІВ РІЗНОЇ СТАТІ. Medical and Clinical Chemistry 2024; (2): 12 doi: 10.11603/mcch.2410-681X.2024.i2.14762
|
| 2 |
Alan C. Logan, Susan L. Prescott, Erica M. LaFata, Jeffrey J. Nicholson, Christopher A. Lowry. Beyond Auto-Brewery: Why Dysbiosis and the Legalome Matter to Forensic and Legal Psychology. Laws 2024; 13(4): 46 doi: 10.3390/laws13040046
|
| 3 |
Laura Žigutytė, Thomas Sorz-Nechay, Jan Clusmann, Jakob Nikolas Kather. Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024. JHEP Reports 2024; 6(12): 101209 doi: 10.1016/j.jhepr.2024.101209
|
| 4 |
Vignesh Rajan, Ambarish Das, J. Venkatachalam, K. K. Lohani, Chandrakant Lahariya. Managing Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Primary Care Settings: A Review. Preventive Medicine: Research & Reviews 2025; 2(4): 183 doi: 10.4103/PMRR.PMRR_159_24
|
| 5 |
Ryan J. Dashek, Taylor J. Kelty, Rory P. Cunningham, Jack Flink, Alexa A. Krause, Grace Shryack, Christopher L. Taylor, Grace M. Meers, Tadashi Yoshida, Srinivas Mummidi, Bysani Chandrasekar, R. Scott Rector. Loss of hepatocyte-specific RECK exacerbates metabolic dysfunction-associated steatohepatitis. American Journal of Physiology-Endocrinology and Metabolism 2025; 329(4): E537 doi: 10.1152/ajpendo.00031.2025
|
| 6 |
Salvatore Pezzino, Stefano Puleo, Tonia Luca, Mariacarla Castorina, Sergio Castorina. Adipokine and Hepatokines in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Current and Developing Trends. Biomedicines 2025; 13(8): 1854 doi: 10.3390/biomedicines13081854
|
| 7 |
Gabrielle Goddard, Shilpa Rajagopal, Gennifer Wahbah Makhoul, Mukaila A. Raji. Metabolic Syndrome in Older Adults: Through the Lens of Institute for Healthcare Improvement’s (IHI) 4Ms Framework and Social Determinants of Health. Life 2025; 15(9): 1370 doi: 10.3390/life15091370
|
| 8 |
Sofia Tamini, Adele Bondesan, Diana Caroli, Nicoletta Marazzi, Alessandro Sartorio. The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity. Journal of Clinical Medicine 2025; 14(7): 2341 doi: 10.3390/jcm14072341
|
| 9 |
Marcelo do Rego Maciel Souto Maior, Nathália de Lacerda Interaminense Ribeiro, Hannah Vicentini Vitoriano Silva, Edmundo Pessoa Lopes, Emilia Chagas Costa. Metabolic Dysfunction-Associated Steatotic Liver Disease as a Risk Factor for Chronic Kidney Disease: A Narrative Review. Biomedicines 2025; 13(9): 2162 doi: 10.3390/biomedicines13092162
|
| 10 |
Bin Hu, Ai-Hong Wan, Xi-Qiao Xiang, Yuan-Hao Wei, Yi Chen, Zhen Tang, Chang-De Xu, Zi-Wei Zheng, Shao-Ling Yang, Kun Zhao. Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis. World Journal of Hepatology 2024; 16(8): 1145-1155 doi: 10.4254/wjh.v16.i8.1145
Abstract(532) |
Core Tip(521) |
Full Article(HTML)(2114)
|
Full Article with Cover (PDF)-3220K(135)
|
Audio-918K(9)
|
Peer-Review Report-173K(85)
|
Answering Reviewers-134K(72)
|
Supplementary Material-24122K(79)
|
Full Article (PDF)-1193K(128)
|
Full Article (XML)-181K(86)
|
Times Cited (0)
|
Total Visits (6541)
|
Open
|
